COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy

COVID-19 infection has had a profound impact on society. During the initial phase of the pandemic, there were several suggestions that COVID-19 may lead to acute and protracted neurologic sequelae. For example, peripheral neuropathies exhibited distinctive features as compared to those observed in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Francisco, Mehra, Ashir, Ensrud, Erik, Diedrich, Daniel, Laudanski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498773/
https://www.ncbi.nlm.nih.gov/pubmed/37712090
http://dx.doi.org/10.3389/fnins.2023.1198327
_version_ 1785105590353133568
author Gomez, Francisco
Mehra, Ashir
Ensrud, Erik
Diedrich, Daniel
Laudanski, Krzysztof
author_facet Gomez, Francisco
Mehra, Ashir
Ensrud, Erik
Diedrich, Daniel
Laudanski, Krzysztof
author_sort Gomez, Francisco
collection PubMed
description COVID-19 infection has had a profound impact on society. During the initial phase of the pandemic, there were several suggestions that COVID-19 may lead to acute and protracted neurologic sequelae. For example, peripheral neuropathies exhibited distinctive features as compared to those observed in critical care illness. The peripheral nervous system, lacking the protection afforded by the blood–brain barrier, has been a particular site of sequelae and complications subsequent to COVID-19 infection, including Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy. We will discuss these disorders in terms of their clinical manifestations, diagnosis, and treatment as well as the pathophysiology in relation to COVID-19.
format Online
Article
Text
id pubmed-10498773
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104987732023-09-14 COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy Gomez, Francisco Mehra, Ashir Ensrud, Erik Diedrich, Daniel Laudanski, Krzysztof Front Neurosci Neuroscience COVID-19 infection has had a profound impact on society. During the initial phase of the pandemic, there were several suggestions that COVID-19 may lead to acute and protracted neurologic sequelae. For example, peripheral neuropathies exhibited distinctive features as compared to those observed in critical care illness. The peripheral nervous system, lacking the protection afforded by the blood–brain barrier, has been a particular site of sequelae and complications subsequent to COVID-19 infection, including Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy. We will discuss these disorders in terms of their clinical manifestations, diagnosis, and treatment as well as the pathophysiology in relation to COVID-19. Frontiers Media S.A. 2023-08-30 /pmc/articles/PMC10498773/ /pubmed/37712090 http://dx.doi.org/10.3389/fnins.2023.1198327 Text en Copyright © 2023 Gomez, Mehra, Ensrud, Diedrich and Laudanski. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Gomez, Francisco
Mehra, Ashir
Ensrud, Erik
Diedrich, Daniel
Laudanski, Krzysztof
COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
title COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
title_full COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
title_fullStr COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
title_full_unstemmed COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
title_short COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
title_sort covid-19: a modern trigger for guillain-barre syndrome, myasthenia gravis, and small fiber neuropathy
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498773/
https://www.ncbi.nlm.nih.gov/pubmed/37712090
http://dx.doi.org/10.3389/fnins.2023.1198327
work_keys_str_mv AT gomezfrancisco covid19amoderntriggerforguillainbarresyndromemyastheniagravisandsmallfiberneuropathy
AT mehraashir covid19amoderntriggerforguillainbarresyndromemyastheniagravisandsmallfiberneuropathy
AT ensruderik covid19amoderntriggerforguillainbarresyndromemyastheniagravisandsmallfiberneuropathy
AT diedrichdaniel covid19amoderntriggerforguillainbarresyndromemyastheniagravisandsmallfiberneuropathy
AT laudanskikrzysztof covid19amoderntriggerforguillainbarresyndromemyastheniagravisandsmallfiberneuropathy

Ejemplares similares